Unity Biotechnology, Inc.
UBX
$0.977
-$0.0067-0.68%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 16.93M | 23.23M | 29.04M | 33.98M | 36.33M |
| Total Receivables | -- | 139.00K | -- | -- | 1.61M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 714.00K | 898.00K | 1.23M | 1.86M | 573.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 17.65M | 24.27M | 30.26M | 35.85M | 38.52M |
|
|
|||||
| Total Current Assets | 17.65M | 24.27M | 30.26M | 35.85M | 38.52M |
| Net Property, Plant & Equipment | 11.73M | 12.36M | 15.77M | 16.53M | 17.29M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 967.00K | 1.04M | 1.10M | 1.15M | 1.10M |
| Total Assets | 30.35M | 37.66M | 47.13M | 53.52M | 58.86M |
|
|
|||||
| Total Accounts Payable | 1.76M | 997.00K | 1.80M | 1.46M | 1.40M |
| Total Accrued Expenses | 3.38M | 4.43M | 3.25M | 3.72M | 2.79M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.93M | 3.83M | 3.73M | 3.64M | 3.54M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 9.07M | 9.26M | 8.78M | 8.82M | 7.73M |
|
|
|||||
| Total Current Liabilities | 9.07M | 9.26M | 8.78M | 8.82M | 7.73M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 18.68M | 19.71M | 20.70M | 21.66M | 22.61M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.81M | 2.20M | 3.51M | 3.29M | 4.54M |
| Total Liabilities | 30.55M | 31.17M | 32.99M | 33.77M | 34.88M |
|
|
|||||
| Common Stock & APIC | 517.44M | 516.82M | 516.01M | 515.21M | 514.17M |
| Retained Earnings | -517.65M | -510.34M | -501.90M | -495.42M | -490.14M |
| Treasury Stock & Other | 1.00K | 15.00K | 39.00K | -35.00K | -38.00K |
| Total Common Equity | -205.00K | 6.49M | 14.14M | 19.75M | 23.99M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -205.00K | 6.49M | 14.14M | 19.75M | 23.99M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -205.00K | 6.49M | 14.14M | 19.75M | 23.99M |
|
|
|||||